🌟**Nutte van Belzen MD** had the immense pleasure to share the stage with three other startups and pitch for the award during the LIFE Science Conference in Groningen.

🤩 This is a golden opportunity in Los Angeles! CC Diagnostics got selected to participate in the HealthTech Mini-Accelerator, a tailor-made program exclusively for Dutch HealthTech startups. This program is a collaborative effort between Cedars-Sinai Accelerator, NBSO Los Angeles and ScaleNL.

CC Diagnostics has successfully completed a large clinical validation study using samples from the Dutch National Screening Program. The results? 97% sensitivity for cancer detection, outperforming the pap smear by 21%—all without compromising specificity. This study, conducted across multiple centers, reflects real-world performance and eliminates bias, marking a significant leap forward in cervical cancer diagnostics.